title: Intralesional recombinant alpha 2a interferon therapy in superficial transitional cell carcinoma of the bladder.
authors.forename: S M
authors.initials: SM
authors.lastname: Di Stasi
authors.forename: A
authors.initials: A
authors.lastname: Tabilio
authors.forename: G
authors.initials: G
authors.lastname: Virgili
authors.forename: G
authors.initials: G
authors.lastname: Vespasiani
authors.forename: M
authors.initials: M
authors.lastname: Porena
authors.forename: F
authors.initials: F
authors.lastname: Micali
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D005260:Female; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins